Replication of Herpes Simplex Virus in Human
Peripheral T Lymphocytes (Accepted 29 July I977) SUMMARY Human peripheral Iymphocytes were separated by the use of neuraminidasetreated sheep red blood cells into a population containing < 2 ~ T cells (population B) and a population containing < z ~ B cells (population T). Population T was able to replicate herpes simplex virus (HSV) after pre-stimulation with the T cell mitogens phytohaemagglutinin and concanavalin A, while population B was not. HSV also did not replicate in population B after pre-incubation with pokeweed mitogen. Our data strongly suggest that in human lymphocyte cultures HSV replicates in activated T cells. Since B cells after removal of T cells were not stimulated by pokeweed mitogen, it is not clear whether human peripheral blood B cells are unable to replicate HSV or whether they may do so only after adequate stimulation.
A number of viruses have been shown to replicate in human leukocyte cultures in vitro (e.g. Edelman & Wheelock, 1968; Miller & Enders, 1968; Willems & Vondrovicova, 197o; Sullivan et al. 1975; Lambriex & van der Veen, I976) . Usually the percentage of cells in such cultures that replicate the virus is quite small and thus this model is not very well suited for studies of molecular virology. However, replication of virus in leukocytes may represent a very important in vivo mechanism for the dissemination of the virus in the bedy (concept of the Trojan horse) and ought to be further characterized.
Herpes simplex virus (HSV) has been shown to replicate in cultmes of human peripheral leukocytes provided they were pre-incubated with certain mitogens such as phytohaemagglutinin (PHA; Nahmias, Kibrick & Rosan, I964; Bouroncle, Clausen & Darner, I97o ) . At the time of these experiments, methods of separating T and B lymphocytes were not available and it was not clear in which cell type replication of HSV took place.
In our experiments we have used peripheral leukocytes from healthy volunteers which were isolated by sedimentation on a Ficoll-Hypaque gradient. The cell population from the interphase containing lymphocytes and a variable percentage of monocytes was collected. Neuraminidase-treated sheep red blood cells (SRBC) were used to separate T and B lymphocytes exactly as described previously (Kirchner, Brunner & Rtihl, 1977) . By this technique we have obtained a population containing < 2 ~ cells forming rosettes with SRBC (population B) and a population containing <2 ~ of cells positive for surface immunoglobulin (population T). These populations were stimulated with optimal doses of mitogens cultivated in tissue culture tubes for 3 days, and subsequently infected with a strain of HSVq, designated HSV (WAL) as described previously (Kirchner et al. 1976 ). The cultures were further incubated for 48 h and frozen at -70 °C. The titres of HSV were determined in a typical virus plaque assay (Kirchner et al. I976) . The degree of lymphocyte activation after the pre-incubation period was determined by the uptake of tritia~ed thymidine (3H-dThd) in a typical lymphocyte stimulation assay (Kirchner et al. I977) . Replication of HSV could be demonstrated in cultures of leukocytes collected from the interphase of the gradient provided that these were first stimulated with PHA, concanavalin A (Con A) or pokeweed mitogen (PWM; see Table I ). Purified T cells when stimulated by these mitogens, showed replication of HSV, while the population B was incapable of virus replication. The unseparated population and population T responded well to the three mitogens when the uptake ofaH-dThd was measured, while population B was unreactive.
Greaves, Janossy & Doenhoff (I974) have previously shown that, as in the mouse, PHA and Con A predominantly stimulate T cells in human blood lymphocyte cultures. In mixtures of T and B cells a small percentage of B cells also responded to the mitogens. Our data show that HSV could be replicated in highly purified T cells after stimulation with PHA and Con A, but not in purified B cell populations. They do not allow us to rule out the possibility that in a mixture of T and B cells, virus replication may take place in some activated B cells.
Unfortunately, at present, it is not possible to test directly whether human B cells activated by a B cell mitogen may also replicate HSV. Rabbit anti-human fl2-microglobulin which is the first described selective B cell mitogen for human peripheral lymphocytes (Ringden, I976) needs the presence of T cells to activate B cells (O. Ringden, personal communication) .
PWM is known to stimulate both T and B cells in human leukocyte cultures (Greaves et al. I974) . In our experiments it was consistently found that population B did not support the growth of HSV when treated with PWM (Table I) . However, purified B cells in the absence of T cells were not stimulated by PWM when the uptake of aH-dThd was measured. Thus, our data do not exclude the possibility that activated B cells when appropriately stimulated may replicate HSV as well as activated T cells. We have recently found that mouse spleen cells were able to replicate HSV only after pre-stimulation with B cell mitogens, such as bacterial endotoxin and depletion experiments have strongly suggested that it was indeed the B cell which replicated HSV (Kirchner et al. 1976) . In contrast to the human data, mouse spleen cells pre-stimulated by the potent T cell mitogens PHA and Con A did not replicate HSV. Mouse spleen cells when treated by the T cell mitogens make interferon (Heine & Adler, 1976) and this certainly complicates the evaluation of the data. However, in unpublished experiments we have shown that treatment of mouse spleen cells with PHA (or Con A) plus LPS did not inhibit the capacity of these cells to replicate HSV, suggesting that interferon did not play a role in this reaction. The same is true for human leukocyte cultures where PHA is known to induce interferon production (Wheelock, 1965) , but nevertheless, lymphocytes stimulated by PHA acquire the ability to replicate HSV.
In conclusion, at the present stage, our data are compatible with the view that in mouse spleen cells HSV replicates in activated B lymphocytes while in human peripheral leukocytes it replicates in activated T lymphocytes. 
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